Edition:
United States

Brainstorm Cell Therapeutics Inc (BCLI.OQ)

BCLI.OQ on NASDAQ Stock Exchange Capital Market

3.11USD
15 Nov 2018
Change (% chg)

$0.04 (+1.14%)
Prev Close
$3.08
Open
$3.03
Day's High
$3.12
Day's Low
$3.03
Volume
2,823
Avg. Vol
10,040
52-wk High
$5.34
52-wk Low
$2.88

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.153
Jun '18 0.00 -0.158
Mar '18 0.00 -0.121
FY 2017 Dec '17 0.00 0.015
Sep '17 0.00 -0.128
Jun '17 0.00 -0.056
Mar '17 0.00 -0.096
FY 2016 Dec '16 0.00 -0.033
Sep '16 0.00 -0.086
Jun '16 0.00 -0.052
Mar '16 0.00 -0.096
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 2 0.75 1.50 0.00 --
Quarter Ending Mar-19 1 1.50 1.50 1.50 --
Year Ending Dec-18 2 0.75 1.50 0.00 0.00
Year Ending Dec-19 2 3.00 6.00 0.00 0.00
Earnings (per share)
Quarter Ending Dec-18 2 -0.09 -0.03 -0.16 -0.31
Quarter Ending Mar-19 1 -0.02 -0.02 -0.02 -0.28
Year Ending Dec-18 2 -0.53 -0.47 -0.59 -1.18
Year Ending Dec-19 2 -0.38 -0.10 -0.66 -1.20
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 80.78 29.53
P/E High - Last 5 Yrs. -- 271.55 46.39
P/E Low - Last 5 Yrs. -- 85.74 24.60
Beta 1.58 0.73 0.87
Price to Sales (TTM) -- 222.00 22.95
Price to Book (MRQ) 6.37 16.68 4.15
Price to Tangible Book (MRQ) 6.37 20.59 13.93
Price to Cash Flow (TTM) -- 49.18 20.94
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.41 1.64
Dividend Yield - 5 Year Avg -- 0.22 1.44
Dividend 5 Year Growth Rate -- 3.68 -6.04
Payout Ratio(TTM) -- 7.83 43.09

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 150.98 6.93
Sales (TTM) vs TTM 1 Yr. Ago -- 62.54 5.64
Sales - 5 Yr. Growth Rate -- 22.39 7.40
EPS (MRQ) vs Qtr. 1 Yr. Ago -19.68 81.55 31.31
EPS (TTM) vs TTM 1 Yr. Ago -33.66 -- --
EPS - 5 Yr. Growth Rate -- 20.67 7.72
Capital Spending - 5 Yr. Growth Rate 14.87 34.65 8.04

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 3.40 2.57
Current Ratio (MRQ) 3.33 6.54 3.54
LT Debt to Equity (MRQ) 0.00 18.54 11.13
Total Debt to Equity (MRQ) 0.00 24.12 15.47
Interest Coverage (TTM) -- -171.25 40.54

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 30.20 54.22
Gross Margin - 5 Yr. Avg. -- 47.69 52.88
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -158.11 15.99
Operating Margin (TTM) -- -1,802.66 -15.93
Operating Margin - 5 Yr. Avg. -- -171.35 11.25
Pre-Tax Margin (TTM) -- -1,733.97 -14.34
Pre-Tax Margin - 5 Yr. Avg. -- -174.09 11.56
Net Profit Margin (TTM) -- -1,729.63 -17.68
Net Profit Margin - 5 Yr. Avg. -- -174.34 7.82
Effective Tax Rate (TTM) -- 14.44 21.42
Effective Tax Rate - 5 Yr. Avg. -- 19.47 24.42

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 24,905,406 736,529,376
Net Income/Employee (TTM) -345,375 -3,414,886 85,218,449
Receivable Turnover (TTM) -- 8.44 5.31
Inventory Turnover (TTM) -- 2.76 4.11
Asset Turnover (TTM) 0.00 0.47 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -66.04 -0.62 10.32
Return on Assets - 5 Yr. Avg. -64.15 2.63 10.91
Return on Investment (TTM) -109.26 -0.25 13.00
Return on Investment - 5 Yr. Avg. -83.18 2.50 14.00
Return on Equity (TTM) -109.26 -3.01 14.69
Return on Equity - 5 Yr. Avg. -84.87 -1.47 15.29
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 1.21 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Brainstorm Cell Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 11.89%
# of Holders: 44
Total Shares Held: 2,461,214
3 Mo. Net Change: -49,649
# New Positions: 5
# Closed Positions: 6
# Increased Positions: 13
# Reduced Positions: 12
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.